COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES

RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon

February 20, 2024



« back to news page